Article Access statistics

Viewed: 717

Emailed: 0

PDF Downloaded: 244

Journal of Pharmaceutical and Biological Sciences


Concurrent analysis of homatropine methylbromide and hydrocodone bitartrate related impurities in reverse phase chromatography by Uplc


Full Text PDF Share on Facebook Share on Twitter


Null

Author Details : Siddareddy Konda, M Aswartha Umakantha Reddy, J. Sreeramulu

Volume : 5, Issue : 4, Year : 2017

Article Page : 161-167


Suggest article by email

Abstract

A Novel, stability indicating reversed phase Ultra performance liquid chromatography (UPLC) method has been developed and validated for simultaneous determination of Homatropine Methyl bromide (HM) and Hydrocodone Bitartrate (HB) related compounds in pharmaceutical dosage form. This chromatographic separation was carried out on an Acquity UPLC using reversed phase column (100 x 2.1 mm, 1.7 µm), a simple gradient program for 40 minutes used. Mobile phase A (buffer) consists a mixture of 14.5 mM sodium phosphate monohydrate, 12.8 mM sodium 1-octanesulfonate monohydrate and 13.8 mM Triethylamine pH adjusted to 2.0 with phosphoric acid, Acetonitrile used as Mobile phase B and mobile phase flow rate used constantly at 0.45 mL Min-1. The chromatography analysis was monitored at 205 nm with column oven temperature at 45 ÌŠC and injection volume as 20 µL. All the components were separated with good resolution in less than 40 minutes. The proposed method has been validated according to ICH guidelines, validation of method showed it to be Specific, Robust, Precise, Accurate and Linear over a range of analysis.

Keywords:
UPLC, Homatropine Methyl bromide, Hydrocodone Bitartrate, Related compounds, Validation


How to cite : Konda S, Reddy M A U, Sreeramulu J, Concurrent analysis of homatropine methylbromide and hydrocodone bitartrate related impurities in reverse phase chromatography by Uplc. J Pharm Biol Sci 2017;5(4):161-167

Copyright © 2017 by author(s) and J Pharm Biol Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)